Marjorie Gwynn, MD
Dermatology · Glen Burnie, MDNPI 1619945557
Payments from drug & device makers
Across 377 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$709
- Pfizer$616
- Sun Pharmaceutical Industries Inc.$563
- Sanofi$555
- Johnson & Johnson$541
- plus $3K from 27 others
What the payments were for
- Food & beverage$7,21299%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,102 |
| Novartis | 43 | $709 |
| Pfizer | 30 | $616 |
| Sun Pharmaceutical Industries Inc. | 26 | $563 |
| Sanofi | 22 | $555 |
| Johnson & Johnson | 24 | $541 |
| Regeneron Healthcare Solutions, Inc. | 23 | $459 |
| Dermavant Sciences, Inc. | 23 | $341 |
| E.r. Squibb & Sons, L.L.C. | 22 | $331 |
| Galderma Laboratories, L.p. | 15 | $293 |
| Lilly USA, LLC | 15 | $253 |
| LEO Pharma Inc. | 11 | $244 |
| UCB, Inc. | 8 | $170 |
| Amgen | 5 | $136 |
| Almirall LLC | 7 | $114 |
| Bristol Myers Squibb | 7 | $111 |
| Boehringer Ingelheim | 4 | $111 |
| Fresenius Kabi USA, LLC | 4 | $79 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $71 |
| Mayne Pharma Commercial LLC | 2 | $71 |
| Nabriva Therapeutics, PLC | 3 | $61 |
| Mission Pharmacal Company | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Incyte Corporation | 2 | $49 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $40 |
| Prugen, Inc. Pharmaceuticals | 3 | $38 |
| Genentech USA, Inc. | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Aclaris Therapeutics, Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Organon | 1 | $15 |
How this compares
$7,312 in reported general payments places this provider in the 70th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 21 | $28,455 |
| Clobetasol Propionate | 83 | $5,173 |
| Fluorouracil | 39 | $2,761 |
| Metronidazole | 34 | $2,002 |
| Doxycycline Hyclate | 26 | $1,068 |
| CiclopiroxCiclopirox Olamine | 20 | $970 |
| Ketoconazole | 43 | $875 |
| Fluocinolone Acetonide | 11 | $720 |
| Clindamycin Phosphate | 15 | $678 |
| Triamcinolone Acetonide | 54 | $621 |
| Betamethasone Valerate | 17 | $434 |
| Ammonium Lactate | 25 | $364 |
| Betamethasone Dipropionate | 12 | $314 |
| Hydrocortisone | 27 | $182 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glen Burnie
- Chikoti WheatGlen Burnie$152K
- Marianne DawnGlen Burnie$15K
- Benjamin LockshinSilver Spring$6.6M
- Shawn KwatraBaltimore$2.4M
- Robert WeissHunt Valley$2.3M
- Rebecca KazinChevy Chase$1.7M
- Chesahna Kindred WeaverMarriottsville$1.4M
- Valerie CallenderGlenn Dale$822K
- Oanh LauringNottingham$763K
- Lloyd MillerBaltimore$752K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.